Anti-CHRFAM7A Antibody

This unconjugated rabbit polyclonal reagent from Antibodies.com targets CHRFAM7A, the hybrid CHRNA7-FAM7A fusion transcript that arises on chromosome 15q13.3 and is widely studied in the context of the alpha-7 nicotinic acetylcholine receptor pathway. Raised in rabbit and supplied as 100 µl of liquid, the antibody is validated for western blot and immunohistochemistry on human and mouse samples, supporting work-up of the 15q13.3 microdeletion region linked to neuropsychiatric and neurodevelopmental phenotypes as well as cholinergic anti-inflammatory signaling research. Its polyclonal format expands the number of accessible epitopes across the fusion-encoded protein, which is useful when characterizing endogenous expression in brain tissue and immune cell models. Researchers studying schizophrenia-associated loci, Alzheimer's-related cholinergic signaling, and the contribution of CHRFAM7A copy number variation to receptor function will find this primary antibody a practical option for downstream western blot and immunohistochemistry workflows in basic research laboratories.